Skip to main content
Submitted by PatientsEngage on 18 May 2019
The hands of a medical professional in a white coat and blue gloves examining the deformed hand of a patient with rheumatoid arthritis

Dr Pravin Patil, Rheumatologist from Pune, Maharasthtra shares the top 7 mistakes that people with Rheumatoid Arthritis with respect to their medications.

People with rheumatoid arthritis (RA) are commonly prescribed several medications. It is very important to take medications regularly and follow correct instructions. It is the responsibility of the patients to know their medications well and avoid making mistakes, which can have serious consequences.

Mistake No. 1: You take Methotrexate daily instead of once a week

Methotrexate, the most commonly prescribed drug for RA. You may be familiar with it by the brand names like folitrax, mexate etc. It is usually taken weekly. Sometimes, it is prescribed twice a week. It should be taken one day a week - on the same day each week (e.g., every Saturday). It is not taken daily like many medications. Methotrexate tablets are available in different strengths like 2.5, 5, 7.5, 10, 15, 20 and 25 mg. The usual starting dose for adults with RA is 15 mg once a week. The total dose of methotrexate in rheumatoid arthritis can be increased to up to 25 mgs each week, if needed.

Too often we come across patients who mistakenly take methotrexate daily rather than weekly. That specific mistake can result in serious side effects related to toxicity. Errors can occur at the pharmacy, too, where mislabelling may direct a patient to take methotrexate daily versus weekly. Know that methotrexate for Rheumatoid Arthritis is a weekly drug.

Mistake No. 2: You forget to take folic acid tablets

Taking folic acid regularly is important to prevent side effects from methotrexate. Usually, folic acid is prescribed two or five days a week. Please note folic acid and methotrexate are completely different drugs. Brand name of methotrexate (e.g. Folitrax) and folic acid (e.g. Folvite, Folimax) could sound similar and add more confusion.

Mistake No. 3: You continue medications even during infection.

If you catch an infection which requires you to take antibiotics it is advised to withhold medications like methotrexate for 2 weeks and inform your rheumatologist.

Mistake No. 4: You stop medications abruptly

Keep taking your medications for the full time of treatment, even if you begin to feel better after a few days. Do not miss any doses. Sudden discontinuation of certain medications may pose a life-threatening situation.

Common reasons to stop medications –

  1. ‘I was worried about side effects’
  2. ‘My parents/relatives suggested me to switch to alternative therapy’
  3. ‘I thought my body will get addicted to medications’
  4. ‘I was feeling fine’

Download Free Toolkit for Managing Arthritis at Home

Mistake No. 5: You alter the dose or treatment regime against medical advice.

It is important to follow all the instruction of the doctor. Many patients try to minimize drug intake by either taking tablets alternate days or half doses. Suboptimal treatment can cause flare up of disease. You may not be aware that certain tablets like sulfasalazine should not be broken. Sulfasalazine comes in the form of enteric-coated tablet and the whole tablet should be swallowed. Do not crush, break, or chew it. This is because they are specially coated to pass through your stomach before they are absorbed. Breaking the tablet could interfere with the special coating.

Mistake No. 6: You don’t tell all your doctors about everything you are taking

All your doctors should know what medications and supplements you are taking. People with RA typically have more than one doctor on their healthcare team. It is important for each of your doctors to have a complete and current medication list for you. Keeping all your doctors informed about your medications will help to prevent drug interactions. Do not neglect to provide each doctor with your full list. It’s your responsibility.

Related Reading: Diabetes Medications and Interactions with other Medicines

Mistake No. 7: You don’t inform your rheumatologist information related to your pregnancy or breastfeeding.

You should consult with your rheumatologist if you are planning to get pregnant. Planning ahead is the key. Some of the drugs used to treat RA can be continued while trying to conceive or even during the pregnancy. Certain medications like methotrexate and leflunomide should be stopped well in advance before you conceive.

Although you may be concerned about the possible harmful effects of taking RA drugs while pregnant, it is important to remember that uncontrolled arthritis during pregnancy can also have adverse effects on your baby such as low birth weight.

My Takeaway Advice

  • Learn about each medication that you are taking.
  • Don’t deviate from the prescribed regimen.
  • Do not stop medications abruptly.
  • Share with rheumatologist if you are planning to get pregnant or taking alternative therapy.

Dr Pravin Patil is a consultant rheumatologist with extensive experience in modern treatment of arthritis and related autoimmune diseases. He has gained vast experience during 10 years of practice in prestigious hospitals in UK like University College London, Royal Free, Whipps Cross and Sounthend University Hospital.  He has published various scientific papers and review articles and has regularly presented his work at the American College of Rheumatology, British Society of Rheumatology.

Condition
Changed
Sun, 05/19/2019 - 19:11

Stories

  • Knee Meniscus fix likely using stem cell procedure
    Researchers report on a revolutionary new procedure that uses 3-D printing and the body’s stem cells to regenerate knee meniscus, a tissue lining that acts as a natural cushion between the femur and tibia. People with damaged menisci develop arthritis and are forced to limit their activity. The procedure, published online Dec. 10 in the journal Science Translational Medicine, has proved successful in sheep at Cornell University six months after surgery, though the researchers will monitor the…
  • Back on her feet after decades of struggle with Rheumatoid Arthritis
    For 48-year-old Sachi Pathak, life was never pain-free. A sports enthusiast, Sachi was always ahead in participating in all gymnastic activities in her school. One day while forming a pyramid (a gymnastic formation) she fell on her knees. Her knees became stiff and her movement became limited. She was rushed to the nearest hospital and over a series of diagnostic tests it was found that she suffered from rheumatoid arthritis.  In Sachi’s case, RA had affected both her knees and hip joints…
  • Cadila launches first cheaper copy of arthritis drug Humira
    Indian drugmaker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its U.S. price. Adalimumab was approved globally in 2002 and has been the most preferred drug for patients suffering from auto immune disorders.  The drug's branded version is sold under the name Humira by U.S. firm AbbVie Inc, and costs $1,000 for a vial in the United States. Humira…
  • Excess weight and food allergies cause arthritis - True or False?
    Find out this and more from Dr Shital Raval  1. Can excess weight cause osteoarthritis? Recent medical opinion points to excess weight as a cause for osteoarthritis. It is also known that obesity makes the symptoms worse in patients with existing osteoarthritis. This is because obesity tends to decrease mobility and puts stress on the back, hips, knees and feet, all the body parts that are commonly affected by osteoarthritis. Over time this stress can cause the…
  • Antibiotic use in children linked to juvenile idiopathic arthritis or juvenile rheumatoid arthritis
    In a new study recently presented at the American College of Rheumatology Annual Scientific Meeting in Boston, MA, researchers have linked antibiotic use in children to increased risk of juvenile idiopathic arthritis or juvenile Rheumatoid Arthritis. The researchers found that children exposed to antibacterial antibiotics - not antifungals or antivirals - were at higher risk of developing JIA than those who had not been exposed to these antibiotics. This risk was higher for children who had…
  • FDA Approves Generic Celebrex
    In June 2014, the U.S. Food and Drug Administration (FDA) approved two generic versions of celecoxib (Celebrex). Developed by Pfizer, celexocib is used to treat rheumatoid arthritis, osteoarthritis, as well as other conditions. Approval was granted to Mylan Pharmaceuticals, Inc. to market 50 mg celecoxib capsules, while Teva Pharmaceutical Industries received approval to market the drug in the following doses: 50 mg, 100 mg, 200 mg, and 400 mg, according to a bulletin from the FDA. Teva was…
  • Inflammation
    Inflammation has been linked to a slew of diseases – from allergies to cancer, heart trouble, bowel problems and diabetes. What is it and how can we protect ourselves. - By paediatrician and family practitioner Dr Gita Mathai. What is inflammation? The word is derived from the Latin “inflammo” meaning ignite or set alight. It conjures up visions of fire, and it is the body’s response to an injury, like a broken bone, a scrape in the skin or an infection by an organism (…
  • Daily exercise may help suppress inflammation in rheumatic disease
    Exercise has been shown to transiently suppress inflammation in an animal model of rheumatic disease, bolstering evidence to support the theory that regular physical activity is beneficial for patients with the disease. “Exercise can be a very potent therapeutic intervention to control inflammatory diseases, but unfortunately today it is underutilized in clinical practice,” said study author Dr. Nicholas Young from The Ohio State University Wexner Medical Center, Columbus, Ohio, US. “[In our…
  • Walking to Help Knee OA: How Much Is Enough?
    Researchers find 6,000 steps per day is the “magic” number for preventing activity limitations in people with knee osteoarthritis (OA), according to a new study published recently online in Arthritis Care & Research. If you have not been doing much walking, start with 3000 steps and then move up to 6000 steps per day http://www.arthritistoday.org/news/walking-protects-against-limitations-348.php
  • Tofacitinib: A novel oral treatment for rheumatoid arthritis
    Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.  http://www.hopkinsarthritis.org/arthritis-news/tofacitinib-fda-approved-oral-biologic-for-rheumatoid-arthritis/